• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19.

作者信息

Al-Samkari Hanny

机构信息

Division of Hematology, Massachusetts General Hospital, Boston.

Harvard Medical School, Boston, Massachusetts.

出版信息

JAMA. 2021 Apr 27;325(16):1613-1615. doi: 10.1001/jama.2021.4295.

DOI:10.1001/jama.2021.4295
PMID:33734290
Abstract
摘要

相似文献

1
Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19.寻找新冠病毒疾病患者的最佳血栓预防剂量
JAMA. 2021 Apr 27;325(16):1613-1615. doi: 10.1001/jama.2021.4295.
2
Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）相关静脉血栓栓塞症的中等剂量血栓预防
Eur J Intern Med. 2021 Jun;88:141-143. doi: 10.1016/j.ejim.2021.03.025. Epub 2021 Mar 26.
3
Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?2019冠状病毒病的血栓预防：抗Xa因子——缺失的因素？
Am J Respir Crit Care Med. 2020 Aug 1;202(3):455-457. doi: 10.1164/rccm.202005-1654LE.
4
A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.时间问题：COVID-19确诊患者静脉血栓预防的持续时间和选择
Br J Hosp Med (Lond). 2020 May 2;81(5):1-2. doi: 10.12968/hmed.2020.0210. Epub 2020 May 18.
5
Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.新冠病毒感染中中等剂量血栓预防的抗Xa因子活性
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1731-1733. doi: 10.1164/rccm.202006-2511LE.
6
Thromboprophylaxis strategies for COVID-19 patients.新冠病毒肺炎患者的血栓预防策略
Arch Med Res. 2022 Jan;53(1):109-110. doi: 10.1016/j.arcmed.2021.06.011. Epub 2021 Jul 5.
7
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey.COVID-19后手术围手术期血栓预防管理：专家小组调查
Br J Anaesth. 2021 Oct;127(4):e143-e145. doi: 10.1016/j.bja.2021.06.041. Epub 2021 Jul 9.
8
[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].[阿根廷COVID-19住院患者血栓预防用药建议]
Medicina (B Aires). 2020;80 Suppl 3:65-66.
9
Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis.接受血栓预防治疗的COVID-19住院患者的重大出血情况。
Thromb Haemost. 2021 Dec;121(12):1670-1673. doi: 10.1055/a-1477-4027. Epub 2021 Jun 6.
10
Thromboprophylaxis in outpatients with COVID-19: a safe bet or tilting at windmills?COVID-19门诊患者的血栓预防：是稳妥之策还是徒劳之举？
Minerva Cardiol Angiol. 2022 Feb;70(1):1-4. doi: 10.23736/S2724-5683.21.05914-7. Epub 2021 Oct 29.

引用本文的文献

1
[Not Available].[无可用内容]
Tunis Med. 2025 Feb 5;103(2):217-224. doi: 10.62438/tunismed.v103i2.5318.
2
Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis.新型冠状病毒肺炎住院期间及出院后的血栓栓塞并发症：发病率、危险因素及血栓预防
Thromb Update. 2022 Mar;6:100096. doi: 10.1016/j.tru.2021.100096. Epub 2022 Jan 3.
3
Genetic risk, adherence to healthy lifestyle and acute cardiovascular and thromboembolic complications following SARS-COV-2 infection.
感染 SARS-COV-2 后的遗传风险、对健康生活方式的坚持与急性心血管和血栓栓塞并发症。
Nat Commun. 2023 Aug 3;14(1):4659. doi: 10.1038/s41467-023-40310-0.
4
An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here?对 COVID-19 血管并发症的基础和管理的不断认识：我们下一步该怎么做？
Can J Cardiol. 2023 Jun;39(6):865-874. doi: 10.1016/j.cjca.2023.03.019. Epub 2023 Mar 24.
5
Therapeutic advances in COVID-19.《COVID-19 的治疗进展》
Nat Rev Nephrol. 2023 Jan;19(1):38-52. doi: 10.1038/s41581-022-00642-4. Epub 2022 Oct 17.
6
Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes.COVID-19 门诊患者的血栓栓塞事件：一项关于发生率和血栓预防结果的观察性研究。
PLoS One. 2022 Aug 4;17(8):e0270195. doi: 10.1371/journal.pone.0270195. eCollection 2022.
7
Thromboprophylaxis in people hospitalized with COVID-19: Assessing intermediate or standard doses in a retrospective cohort study.COVID-19住院患者的血栓预防：一项回顾性队列研究中评估中等剂量或标准剂量
Res Pract Thromb Haemost. 2022 Jul 15;6(5):e12753. doi: 10.1002/rth2.12753. eCollection 2022 Jul.
8
Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments.新型冠状病毒病 2019 心血管并发症的综合综述及有益治疗方法。
Cardiol Rev. 2022;30(3):145-157. doi: 10.1097/CRD.0000000000000422.
9
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
10
COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort.与流感相比，COVID-19 与静脉血栓形成的风险增加相关，而与动脉血栓形成无关：来自美国大型队列的研究结果。
PLoS One. 2022 Jan 12;17(1):e0261786. doi: 10.1371/journal.pone.0261786. eCollection 2022.